There are still a few seats available in the upcoming Post–award Focus: Federal Grant Management workshop, where, through analysis of case studies, participants will consider the new OMB Uniform Guidance, the NIH Grants Policy Statement, “single-draw,” closeout rules, and OHSU forms and procedures.
Wednesday, Dec. 10, 2014
1 to 4 p.m.
Key course topics:
- Post-award roles and responsibilities
- Cost principles
- Prior approval
- Subrecipient monitoring
Ideally, participants will have completed Essentials of Grant Administration or have equivalent experience, as well as Oracle Grants Accounting.
Enroll using your network credentials through Compass. For questions, contact Margaret Gardner at firstname.lastname@example.org.
Are you submitting a Career Development K award? Or your first R01? A similar major grant?
The Oregon Clinical and Translational Research Institute has an opportunity for basic and clinical scientists to present their research and get constructive feedback from OHSU scientists to improve their chances of success. The OCTRI Design Studio has helped many OHSU researchers improve their aims and identify important areas of improvement before submitting awards.
The Design Studio has openings at three scheduled meetings for this
- Monday, Dec. 15, 1 to 3 p.m., Kohler Pavilion 13000A
- Tuesday, Jan. 13, 12 to 2 p.m., Kohler Pavilion 13000A
- Tuesday, Feb. 10, 12 to 2 p.m., Kohler Pavilion 13000A
OCTRI’s Design Studio has been a great opportunity for basic scientists as well as clinical scientists at all levels of training. Learn more about Design Studio, or contact Karen McCracken about presenting.
The office of Technology Transfer & Business Development presents:
The basics of starting a company in an academic setting: Things you should know, follow or avoid
Are you interested in starting a company based on your invention?
The Director of Business Development, Jit Banerjee, and the Startup Development Associate, Daphne Emerson, will take you through the basic steps to starting a company based on your technology, including:
- IP protection and assessment
- Option or license negotiation
- The initial startup team meeting
- The final approval process
They will also review a list of startup launch steps – from company incorporation, to registering with the federal procurement system, to developing a website for your company. Non-dilutive and dilutive funding, including the basics of SBIR/STTR grants, will also be briefly discussed.
Tuesday, Dec. 16, 2014
12 to 1 p.m.
OHSU Marquam Hill Campus
Mackenzie Hall 2201
Add it to your CALENDAR
This event is open to all OHSU employees, faculty and students. Admission is free, and no RSVP is necessary. The event will be catered. Lunches will be provided on a first-come, first-served basis. For any questions regarding this event, please e-mail Karen Boren at email@example.com.
Join the Oregon Clinical and Translational Research Institute, OCTRI, in a monthly research forum that addresses all things clinical and translational research.
Don’t miss December’s topic: Power and Sample Size Simplified
Refresh your skills on calculating power and sample size for your research proposal. Work through examples in clinical and translational research and learn about tools and resources available to you through the Biostatistics and Design Program. Presented by David Yanez.
Presenter David Yanez
Friday, Dec. 12, 2014
12 to 1 p.m.
Mackenzie Hall 2201
OCTRI invites all faculty and staff to discuss issues and solutions to common obstacles in conducting clinical and translational research. Do you have a clinical or translational research question? Let us know, and we’ll do our best to help during these events! Please submit questions and topic requests to Colleen Berreta.
Click here for more information about the OCTRI Research Forum.
Save the date!
January OCTRI Research Forum: Survey Design and Tools
Jan. 26, 2015
12 to 1 p.m.
Mackenzie Hall 2201
Building partnerships between academic and corporate institutions is a mutually beneficial endeavor. These types of alliances have the potential to innovate and solve many medical, scientific, and health-related issues. Universities can bring a wealth of knowledge and research expertise, while partnering corporations provide the resources and connections necessary to help that research flourish. Although the paths to these partnerships can vary by institution, scientific alignment is the foundation of prosperous relationships.
The pharmaceutical, medical device, and biotech industries have a long history of collaboration with academia. When the goals of both parties are aligned, successful, long-term partnerships are much more likely to develop. The common paths taken for academic-corporate partnerships include:
- Companies collaborating directly with individual faculty that may have unique expertise or resources
- Faculty submitting either solicited or unsolicited proposals followed by internal evaluation and selection by the industry partner
- An organization-to-organization broad, strategic relationship involving multiple projects
- Consortia of companies and/or academic organizations
How can the success of these partnerships be ensured? First, both parties must be clear in outlining their goals up front in order to make the process as transparent as possible. Communication is critical when developing a new partnership. Second, decision makers must be accessible and openly supportive of development of the relationship. Third, project managers with strong collaboration skills and the necessary bandwidth in their schedules should be assigned to developing and maintaining the relationship.
There are few things to keep in mind when beginning this process:
- When you find a potential prospect, it is important to remain flexible and responsive.
- Due diligence at the beginning is normal and takes time.
- Remember that most industry RFPs do not get funded, but often times feedback is provided, including options for re-submission.
- Be patient. Relationship development can be a lengthy process as both institutions get to know each other.
TTBD periodically sends out Requests for Proposals solicited by different pharmaceutical and medical device companies. We encourage you to look at their websites for submission criteria in your areas of interest. Contact us if you plan on submitting a proposal and/or are in need of any guidance.
For more information, please contact our office at firstname.lastname@example.org.
It seems like it was just yesterday that the previous Effort Certification cycle came to a close. The end of yet another effort cycle occurs on Dec. 31. Get a jump on your effort tracking and reporting process by considering these upcoming RATE classes:
Effort Certification – Tuesday, Dec. 2, 2014, 1 to 3 p.m. in CHH 3181 1B
Examine not only the federal requirements that shape institutional policy but also details of OHSU’s Effort Certification procedure, including reporting frequency and shared compliance responsibility. This class is for department Effort Coordinators and those supporting or overseeing the effort to certify Effort.
DHHS Salary Cap - Tuesday, Dec. 9, 2014, 1 to 3 p.m. in CHH 3181 1B
Gain tools for navigating the complex process of budgeting for and managing salaries affected by the DHHS Salary Cap. It’s recommended that participants have attended Effort Certification before this class.
Enrollment for either or both of these classes is now through Compass using your network credentials. For questions about this or any other RATE Classes, please contact Margaret Gardner.
Accounting of Disclosures
Ron Marcum, M.D., M.S., CHPS
Chief Privacy Officer and Information Security Officer
OHSU Information Privacy and Security Office
Thursday Dec. 11, 2014
11:30 a.m. to 12:30 p.m.
Do you do research under a Waiver of HIPAA Authorization or a Decedents Representation? Did you know that if you send/share Protected Health Information (PHI) outside of OHSU, you need to track those disclosures in OHSU’s electronic Accounting of Disclosures system?
Attend this brown bag session to learn about:
- HIPAA’s Accounting of Disclosures requirement
- When you need to track disclosures in a research study
- How to use OHSU’s electronic Accounting of Disclosures system
- Upcoming changes to the Waiver of Authorization and Decedents forms to help ensure compliance with these requirements
Eric Gouaux, Ph.D.
OHSU’s Dr. Eric Gouaux, senior scientist and principal investigator in the Vollum Institute, this week was awarded an honorary doctorate by the University of Copenhagen for research of the molecular principles underpinning the structure and function of chemical synapses. The award was conferred as part of a symposium organized on behalf of the university’s Drug Research Academy. Dr. Gouaux was the symposium’s keynote speaker, presenting on the topic “Atomic architecture and molecular choreography at the chemical synapses of the brain.”
Honorary doctorates—which are a tradition that goes back to the Middle Ages—are awarded to researchers in recognition of their scientific endeavors and are the highest academic accolade that the University of Copenhagen confers. The vast majority of honorary doctorates are conferred on non-Danish scientists who, as visiting teachers or through international research collaboration, have played a significant role in research and researcher training at the University of Copenhagen. Congratulations to Dr. Gouaux!
The Medical Research Foundation of Oregon has announced the recipients of its 2014 awards for scientific leadership and innovation in Oregon. The awards were presented Wednesday, Nov. 12.
Established in 1942, the MRF promotes medical research achievement across the state. In addition to awarding its annual leadership and innovation honors, it administers more than $1 million in annual research funding and early investigator grants that support the work of outstanding investigators at research institutions across the state.
Fay Horak, Ph.D.
The Mentor Award was presented to Fay Horak, Ph.D., professor of neurology in the OHSU School of Medicine, and physical therapist and motor control neurophysiologist in the OHSU Parkinson Center of Oregon. Horak’s research focuses on neurological disorders that affect balance and gait. Horak was recognized for being a coach, collaborator, adviser and advocate who contributed to the success of 47 postdoctoral fellows, including numerous MRF grant recipients. Many of her former trainees now hold faculty positions around the world.
George Bailey, Ph.D.
The Discovery Award was presented posthumously to George Bailey, Ph.D., distinguished professor emeritus in the Department of Environmental and Molecular Toxicology and retired principal investigator at the Linus Pauling Institute at Oregon State University. Bailey helped pioneer the use of rainbow trout in studying carcinogens. His work in cancer chemoprevention has the potential to dramatically limit colon and liver cancer rates in many regions of the world. His research changed the understanding of carcinogens, especially exposures relevant to humans. Bailey died Oct. 20 following a serious illness.
Joshi J. Alumkal, M.D.
The Richard T. Jones New Investigator Award was presented to Joshi J. Alumkal, M.D., associate professor of medicine and molecular and medical genetics in the OHSU School of Medicine, and co-leader of the OHSU Knight Cancer Institute’s Prostate Cancer Research Program. Alumkal is a physician-scientist whose work on developing more effective treatments for advanced prostate cancer patients has had a significant impact in Oregon and beyond. Alumkal’s research is focused on understanding molecular mechanisms by which lethal prostate cancers evolve.
Susan Tolle, M.D.
The 2014 MacLean Center Prize in Clinical Ethics was presented to Susan Tolle, M.D., at the 26th annual Dorothy J. MacLean Fellows Conference in Chicago earlier this month. Tolle, a professor of medicine at OHSU and director of the OHSU Center for Ethics in Health Care, is one of the founders of the Physician Orders for Life-Sustaining Treatment (POLST) movement in Oregon. The MacLean Prize, an award of $50,000, is the largest award in the clinical medical ethics field. Tolle is putting her prize money back into the OHSU’s Center for Ethics in Health Care, which she directs, becoming the first MacLean Center recipient to donate her award money.
The MacLean Center, which pioneered the formal study of clinical medical ethics in the early 1980s, has the world’s largest clinical medical ethics program for health care providers. Read more about Dr. Tolle’s award in The Oregonian.